SCHEMBL9613085

SCHEMBL9613085

c1cc(-c2ccncc2)nc(-c2ccc(-c3c4ccccc4c(-c4cccc5ccccc45)c4ccccc34)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
MAPT P10636 5/20 0.48
HPGD P15428 5/20 0.48
RAB9A P51151 4/20 0.48
KDM4E B2RXH2 4/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
NPC1 O15118 3/20 0.48
HSD17B10 Q99714 3/20 0.48
MAPK1 P28482 2/20 0.48
LMNA P02545 1/20 0.48
MAPK11 Q15759 2/20 0.43
MAPK14 Q16539 2/20 0.43
MAPK13 O15264 1/20 0.43
GCGR P47871 1/20 0.43
MAPK12 P53778 1/20 0.43
CYP2C9 P11712 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
AR P10275 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13658695 0.92 RAB9A (0.49) ALDH1A1MAPTHPGDRAB9AKDM4E
SCHEMBL9612925 0.91 MAPT (0.53) ALDH1A1MAPTHPGDRAB9AKDM4E
SCHEMBL14461161 0.91 MAPT (0.55) ALDH1A1MAPTHPGDRAB9AKDM4E
SCHEMBL13658690 0.90 RAB9A (0.45) ALDH1A1MAPTHPGDRAB9AKDM4E
SCHEMBL17754136 0.89 MEN1 (0.53) ALDH1A1MAPTHPGDRAB9AKDM4E
SCHEMBL17320779 0.85 KMT2A (0.48) ALDH1A1MAPTHPGDRAB9AKDM4E
SCHEMBL13658704 0.84 RAB9A (0.45) ALDH1A1MAPTHPGDRAB9AKDM4E
SCHEMBL13979054 0.83 NOTUM (0.46) ALDH1A1MAPTHPGDRAB9AKDM4E
SCHEMBL9612929 0.83 KDM4E (0.51) ALDH1A1MAPTHPGDRAB9AKDM4E
SCHEMBL17320820 0.82 KDM4E (0.46) ALDH1A1MAPTHPGDRAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9887365-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2018-02-06 US disclosed
US-9887365-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2018-02-06 US disclosed
US-20160141513-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-05-19 US disclosed
US-20160141513-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-05-19 US disclosed
US-9296695-B2 Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-03-29 US disclosed
US-9296695-B2 Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-03-29 US disclosed
WO-2012070535-A1 ELECTRON TRANSPORT MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME JNC株式会社 (JP) 2012-05-31 WO disclosed
EP-2110373-A1 Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same Samsung Mobile Display Co., Ltd. (KR) 2009-10-21 EP disclosed
US-20090256473-A1 BIPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE EMPLOYING ORGANIC LAYER COMPRISING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2009-10-15 US disclosed
US-20090256473-A1 BIPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE EMPLOYING ORGANIC LAYER COMPRISING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2009-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090256473-A1 BIPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE EMPLOYING ORGANIC LAYER COMPRISING THE SAME OCIAD2, OCIAD1, DRD2 ALDH1A1 576/4885MAPT 214/4885HPGD 1356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.